Our early access program will begin in September 2021 and will launch first in the Greater Boston, Northampton MA and Chicago areas. If you'd like to apply for early access to eo just tap the green button above. If you'd like to be notified when eo will be available in your area, sign-up above to receive our newsletter or follow us on any of our social media channels.

At eo, we're committed to enabling the most premium cannabis care at accessible prices. While exact pricing is still being determined, here's how eo works:

While our early access program is free to qualified patients, for others we will ultimately charge a fee for the first 30 days of eo care, during which they receive their personalized care plan and shopping list, provide in-session and end-of-day feedback and collaborate with our care team until they've realized their optimal cannabis care regimen. Along the way, they can purchase nicely priced telemedicine consults or packages of consults anytime.

After the first 30 days of care, the patient can transition to a lower-priced, monthly fee that maintains their access to continually tuned and updated care plans, discounted products, our clinician-trained guides and nicely-priced telemedicine consults.

In order to increase access to eo, we're also currently negotiating bespoke partnerships with leading providers and provider networks, cannabis retail and delivery partners and cannabis producers.

No medical card is required for patients to use eo. However, in many states having a card enables access to a broader range of products at lower prices. For this reason, our care team will recommend and provide cards for qualified patients as appropriate.

Yes. Patient privacy is fundamental and only appropriately anonymized and formatted data sets will be shared with our clinical and commercial partners.

Furthermore, eo is designed and built to anticipate the eventual removal of cannabis from Schedule I of the Controlled Substances Act,  the potential federal legalization of medical cannabis and likely FDA oversight.

Many companies and researchers are now doing the extremely hard work of attempting to determine with a meaningful degree of replicability and consistency which specific cannabis compounds are most useful in the treatment of specific maladies. Our iterative, efficient approach to patient experience design and our unique data model will help all parties address these truly difficult problems.

With that said, our primary goal is to define patient experience and data model designs that will allow any one person to most rapidly arrive at the cannabis care regimen that best addresses their pain, sleeplessness or anxiety/depression, improves their overall well-being and their quality of life. Then we partner with them over time to tune that regimen as their body, their mind, their life and the products themselves evolve. Or put another way: Our focus is on perpetually working to understand which products, taken at which dose, at which time of day, in which context, will help any one person feel and live best.

It's our belief that focusing on individual success is the best way to ultimately find the specific connections and insights that will one day be broadly applicable beyond the individual - and create the future of cannabis medicine.

Yes. With minor adjustments our companion app and data model can be deployed by clinicians in other specialties towards most established and emerging pain, sleeplessness or anxiety/depression treatments. Where patient/clinician collaboration, timely feedback, iteration and data are highly valued, eo may be very useful.